NCT04997902 2025-12-23Combination Trial of Tipifarnib and Alpelisib in Adult Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)Kura Oncology, Inc.Phase 1/2 Completed45 enrolled
NCT02383927 2024-07-11Phase II Study of Tipifarnib in Squamous Head and Neck Cancer With HRAS MutationsKura Oncology, Inc.Phase 2 Completed63 enrolled 19 charts